National Council for Prescription Drug Programs

Award-Winning Pharmacist and Biopharmaceutical Entrepreneur Dr. David Dalton Honored with "BANNERED HERO" Award from Sigma Pi Phi Fraternity

Retrieved on: 
Saturday, October 14, 2023

HARRISBURG, Pa., Oct. 13, 2023 /PRNewswire/ -- Dr. David Dalton, an award-winning pharmacist and biopharmaceutical entrepreneur, was recently recognized as one of twelve 'BANNERED HEROES' at a celebration for Pennsylvania's African American Veterans hosted by The State Museum of Pennsylvania and Sigma Pi Phi Fraternity.

Key Points: 
  • In partnership with the State Museum of Pennsylvania, BANNERED HEROES is sponsored by the Beta Pi Boulé Chapter (Harrisburg, PA) of Sigma Pi Phi Fraternity (the Boulé), of which Dr. Dalton is a member.
  • Young, Colin Powell, James E. Clyburn, John Lewis, Wynton Marsalis, Barak Obama, Kenneth Chenault and Wes Moore, among others.
  • The Boulé is committed to elevating Black communities by striving to eliminate barriers to civic, social, political, educational and economic well-being.
  • Dr. Dalton is also one of the 18 veterans to have a banner hanging in Pennsylvania's Soldiers Grove, located behind the capitol.

The Exceptional Women Alliance (EWA) announces selection of Melanie Marcus, Chief Marketing and Customer Experience Officer, Surescripts, as a 2023 Awardee

Retrieved on: 
Wednesday, August 2, 2023

LOS ANGELES, Aug. 2, 2023 /PRNewswire-PRWeb/ --The Exceptional Women Alliance (EWA) announces the selection of 2023 awardee Melanie Marcus, Chief Marketing and Customer Experience Officer for Surescripts. With over 30 years of experience working at the intersection of marketing, technology, and healthcare, her role of "chief storyteller," helps people understand how technology unites our fragmented healthcare system. She also currently hosts Surescripts' award-winning podcast, There's A Better Way: Smart Talk on Healthcare and Technology.

Key Points: 
  • The Exceptional Women Alliance (EWA) announces that after an expansive search and in-depth interview process, Melanie Marcus, Chief Marketing and Customer Experience Officer of Surescripts, was selected as a 2023 EWA.
  • LOS ANGELES, Aug. 2, 2023 /PRNewswire-PRWeb/ --The Exceptional Women Alliance (EWA) announces the selection of 2023 awardee Melanie Marcus, Chief Marketing and Customer Experience Officer for Surescripts.
  • Ms. Marcus has a robust background as a healthcare marketing, customer experience and strategic executive.
  • "We are thrilled to welcome Melanie with her rich background in marketing and passion for enabling people to excel.

Surescripts to Present New Data on Opportunities to Expand Access & Fill Gaps in Primary Care and More at NCPDP 2023 Annual Technology & Business Conference

Retrieved on: 
Friday, April 28, 2023

Shannon Reidt , Director of Medication Research and Analytics at Surescripts, will present new data and analysis that supports the opportunity for evolving care teams, including pharmacists, to help fill gaps in primary care so patients will continue to have access to essential services.

Key Points: 
  • Shannon Reidt , Director of Medication Research and Analytics at Surescripts, will present new data and analysis that supports the opportunity for evolving care teams, including pharmacists, to help fill gaps in primary care so patients will continue to have access to essential services.
  • Nearly half of all counties in the United States have relative shortages of primary care providers (PCPs), with just one PCP for every 1,500 people.
  • Surescripts is a member and sponsor of NCPDP , supporting dozens of workgroups that inform leading pharmacy industry standards.
  • Where to Find Surescripts at NCPDP:
    Speaking session: Opportunities to Expand Access & Fill Gaps in Primary Care, Tuesday, May 9, 3:10—3:30 p.m., in the Innovation Theater
    Under intense pressure, today’s care team is evolving—and new data shows that pharmacies have a unique opportunity to improve access to primary care.

NCPDP Selects H1 as Exclusive Provider Data Partner

Retrieved on: 
Wednesday, April 12, 2023

NEW YORK, April 12, 2023 (GLOBE NEWSWIRE) -- H1 , the connecting force for global healthcare provider, clinical, science, and research information, today announced that the National Council for Prescription Drug Programs ( NCPDP ) has selected H1’s provider data to power its prescriber database, HCIdea®.

Key Points: 
  • NEW YORK, April 12, 2023 (GLOBE NEWSWIRE) -- H1 , the connecting force for global healthcare provider, clinical, science, and research information, today announced that the National Council for Prescription Drug Programs ( NCPDP ) has selected H1’s provider data to power its prescriber database, HCIdea®.
  • NCPDP’s HCIdea is now powered by H1, which continually contributes and updates provider data including name, gender, NPI, licenses, birth date, address, contact information, education, training, and more to be readily accessible.
  • By partnering with H1, NCPDP is offering its HCIdea subscribers a way to access the right data at the right time on the right prescribers to reduce costs and risks associated with inaccurate data.
  • We are honored that NCPDP selected H1 as its new data partner and feel that it validates our ability to provide the most accurate prescriber information possible,” said Ariel Katz, CEO and co-founder, H1.

E-Prescribing Market to Hit $19.28 Billion by 2030: Grand View Research, Inc

Retrieved on: 
Tuesday, January 24, 2023

On the other hand, improving healthcare infrastructure and increasing healthcare expenditure in developing countries are anticipated to provide numerous growth opportunities for the market.

Key Points: 
  • On the other hand, improving healthcare infrastructure and increasing healthcare expenditure in developing countries are anticipated to provide numerous growth opportunities for the market.
  • North America held a major market share of over 40% in 2022, owing to government initiatives and incentive programs.
  • Key players in the market are investing in the launch of new products and collaborations for sustaining the market.
  • Grand View Research has segmented the global e-prescribing market based on product, delivery mode, usage methods, substances, specialties, end-use, and region
    E-Prescribing Market - Product Outlook (Revenue, USD Million, 2017 - 2030)

E-Prescribing Market to Hit $19.28 Billion by 2030: Grand View Research, Inc

Retrieved on: 
Tuesday, January 24, 2023

On the other hand, improving healthcare infrastructure and increasing healthcare expenditure in developing countries are anticipated to provide numerous growth opportunities for the market.

Key Points: 
  • On the other hand, improving healthcare infrastructure and increasing healthcare expenditure in developing countries are anticipated to provide numerous growth opportunities for the market.
  • North America held a major market share of over 40% in 2022, owing to government initiatives and incentive programs.
  • Key players in the market are investing in the launch of new products and collaborations for sustaining the market.
  • Grand View Research has segmented the global e-prescribing market based on product, delivery mode, usage methods, substances, specialties, end-use, and region
    E-Prescribing Market - Product Outlook (Revenue, USD Million, 2017 - 2030)

IR-Med Announces Dr. David Dalton as Advisory Board member

Retrieved on: 
Wednesday, November 16, 2022

Rosh Pinna, Israel, Nov. 16, 2022 (GLOBE NEWSWIRE) -- "IR-MED” or the "Company") (OTCQB:IRME), an innovative medical device company that develops non-invasive, real-time detection devices that utilize Infrared Light Spectroscopy (IR) and Artificial Intelligence (AI) for use by healthcare professionals, welcomes Dr. David Dalton to the Company's Advisory Board. As part of the Advisory Board, Dr. Dalton will offer insights on the company's PressureSafe device for the early detection of pressure injuries (PI). Dr. Dalton will support IR-Med with analyzing the benefits of the PressureSafe device for Hispanic and African American populations in the United States, two groups that, according to a study, published on Pubmed.gov, suffer from pressure wounds almost twice as much as the Caucasian population due to late discovery.

Key Points: 
  • As part of the Advisory Board, Dr. Dalton will offer insights on the company's PressureSafe device for the early detection of pressure injuries (PI).
  • Dr. David Dalton is a hall of fame CEO, entrepreneur, pharmaceutical executive, and founder of over 40 companies.
  • He is currently Board Director and Executive Chairman of six companies and leads the chain drug industry as the first black executive.
  • His accolades include being an inductee in three halls of fame and a recipient of the Senatorial Medal of Freedom.

NCPDP Foundation Awards $295,000 in Grants to Enhance Patient Safety, Expand Patient Access to Care, & Expand the Role & Value of Pharmacists

Retrieved on: 
Thursday, July 28, 2022

SCOTTSDALE, Ariz., July 28, 2022 /PRNewswire-PRWeb/ -- The NCPDP Foundation Board of Trustees announced it has awarded a total of $295,000 in grants in its first grant award cycle of 2022. The grants fund research that will examine the value and untapped potential of the RxFill or RxChange transactions in NCPDP's SCRIPT Standard for ePrescribing. The grants support the NCPDP Foundation's strategic initiatives to Enhance Patient Safety, Expand Patient Access to Care, and Expand the Role and Value of the Pharmacist.

Key Points: 
  • Research Projects will Explore the Value and Untapped Potential of the RxFill or RxChange Transactions in the NCPDP SCRIPT Standard.
  • The grants support the NCPDP Foundation's strategic initiatives to Enhance Patient Safety , Expand Patient Access to Care , and Expand the Role and Value of the Pharmacist .
  • Last month the NCPDP Foundation issued its second 2022 call for grant proposals that demonstrate the value of NCPDP standards in supporting patient safety, access to care and the expanded role of pharmacists.
  • The NCPDP Foundation was established in December 2012 to support research, education, and charitable involvement within the healthcare industry.

NCPDP Foundation Awards Grant to University of Arizona R. Ken Coit College of Pharmacy to Identify Barriers to Using Indication/Diagnosis Fields in NCPDP Standards

Retrieved on: 
Monday, June 27, 2022

SCOTTSDALE, Ariz., June 27, 2022 /PRNewswire-PRWeb/ -- The NCPDP Foundation Board of Trustees announced it has awarded a $60,000 grant to the University of Arizona R. Ken Coit College of Pharmacy to research and identify barriers to using the clinical indication (SNOMED CT) or diagnosis (ICD-10) fields in NCPDP's SCRIPT and Telecommunication Standards, which can aid pharmacists in drug utilization review, and improve patient care and patient safety. Pharmacy associations and medication safety organizations have long advocated for use of clinical indication or diagnosis on medication orders, and NCPDP strongly recommends use of the fields in all prescriptions. Use of the fields also supports pharmacists in providing prospective and retrospective drug utilization review (DUR) mandated by the Omnibus Budget Reconciliation Act of 1990 (OBRA 90) as well as laws or regulations enacted at the state level. The research project will produce a prioritized needs assessment to guide the action steps toward addressing and overcoming perceived barriers and concerns related to the routine exchange of clinical indication or diagnosis between prescribers and pharmacies in the ambulatory care setting.

Key Points: 
  • Pharmacy associations and medication safety organizations have long advocated for use of clinical indication or diagnosis on medication orders, and NCPDP strongly recommends use of the fields in all prescriptions.
  • The NCPDP Foundation grant to the University of Arizona R. Ken Coit College of Pharmacy was made possible by the Mary and Charles D. Pulido Endowment Fund as granted to the NCPDP Foundation by the NCPDP Board of Trustees.
  • The NCPDP Foundation is a 501(c)(3) nonprofit charitable organization headquartered in Scottsdale, Arizona and is affiliated with the National Council for Prescription Drug Programs (NCPDP).
  • The NCPDP Foundation was established in December 2012 to support research, education, and charitable involvement within the healthcare industry.

AMIH Subsidiary EPIQ Scripts Receives Pharmacy License with Texas State Board of Pharmacy

Retrieved on: 
Thursday, June 16, 2022

Dallas, Texas, June 16, 2022 (GLOBE NEWSWIRE) -- American International Holdings Corp. (OTCQB: AMIH)(AMIH or the Company), adiversified holding company that develops, acquires and operates technology-based health and wellness companies, is pleased to announce that its subsidiary, EPIQ Scripts, LLC (EPIQ Scripts), has received a pharmacy license from the Texas State Board of Pharmacy (TSBP).

Key Points: 
  • Dallas, Texas, June 16, 2022 (GLOBE NEWSWIRE) -- American International Holdings Corp. (OTCQB: AMIH)(AMIH or the Company), adiversified holding company that develops, acquires and operates technology-based health and wellness companies, is pleased to announce that its subsidiary, EPIQ Scripts, LLC (EPIQ Scripts), has received a pharmacy license from the Texas State Board of Pharmacy (TSBP).
  • In addition to obtaining a pharmacy license from the TSBP, EPIQ Scripts has also obtained its National Provider Identifier (NPI) number and is now a member of the National Council for Prescription Drug Programs (NCPDP), a standards development organization.
  • EPIQ Scripts plans to operate as an online mail-order compounding pharmacy, with a specific target to service and support telehealth and telemedicine companies, and their respective customers and patients, that have been rapidly entering into the market.
  • ft., (ii)submitted its application with the Utilization Review Accreditation Commission (URAC), (iii) obtained its pharmacy license from the Texas State Board of Pharmacy, (iv) become a member of the NCPDP, and (v) received its National Provider Identifier (NPI) number.